A phase I study of veliparib (ABT-888) in combination with capecitabine (C) and temozolomide (T) in patients (pts) with advanced well-differentiated unresectable neuroendocrine tumors (wdNET).

Authors

null

Ramya Thota

Vanderbilt University School of Medicine, Nashville, TN

Ramya Thota , Kimberly Brown Dahlman , Tatsuki Koyoma , Jordan Berlin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Translational Research

Citation

J Clin Oncol 34, 2016 (suppl 4S; abstr TPS466)

DOI

10.1200/jco.2016.34.4_suppl.tps466

Abstract #

TPS466

Poster Bd #

N16

Abstract Disclosures

Similar Posters

First Author: Nataliya Volodymyrivna Uboha

First Author: Edward Samuel James

First Author: Shubham Pant

First Author: Edward Samuel James